Cervical Cancer Screening in Transgender Men and Non-Binary People with a Cervix


  • Tessa Anzai McMaster University
  • Amanda Selk University of Toronto
  • Julie My Van Nguyen McMaster University


Transgender health, Cervical cancer, Cancer screening, Reproductive health


Mortality from cervical cancer is projected to decline over the next several years; however, this estimate relies on the inclusion of all eligible individuals in screening processes. This requires a robust understanding of barriers to routine screening, especially in at-risk populations such as transgender men and those who identify across a trans-masculine spectrum. Barriers include miseducation surrounding screening protocols, distrust in the healthcare system and histological inadequacy of samples obtained. These barriers can be addressed through proper education of both practitioner and patient, appropriate signage and outreach, and adjustments to clinical practices to meet evolving guidelines.

Author Biographies

Tessa Anzai, McMaster University

Tessa Anzai is a second year medical student at McMaster University, and she holds a Joint Honours Bachelor of Science in Biology & Psychology. She is actively involved in student leadership and has clinical and academic interests in internal medicine, geriatrics, and women’s health.

Amanda Selk, University of Toronto

Dr Amanda Selk is an Associate Professor in the Department of Obstetrics and Gynecology at the University of Toronto. She is the president of the Society of Canadian Colposcopists and the President of the International Society for the  Study of Vulvovaginal Disease North American Chapter. She is the host of the podcast “The Vulva Diaries”.

Julie My Van Nguyen, McMaster University

Dr Julie My Van Nguyen is an Assistant Professor at McMaster University, Gynecologic Oncologist at the Juravinski Hospital and Cancer Centre, and she holds an MSc in Quality Improvement and Patient Safety. Her research interests include perioperative care, frailty and aging, and advancing equity and inclusion in clinical care and academic medicine.